Our data show that chemotherapy profoundly alters the PDAC TME, inducing features consistent with tumor progression and refractoriness to immunotherapy by downregulation of inhibitory checkpoint molecules in CD8 + T cells. The gene discussed is CD8A; the disease is neoplasm.